Covered recipient · General Payments record
SARDION JIJELAVA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2021–2024
$851.00
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $411.63 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Grifols USA, LLC | $133.52 | 1 |
| ABBVIE INC. | $131.28 | 6 |
| Teva Pharmaceuticals USA, Inc. | $117.66 | 1 |
| SK Life Science, Inc. | $29.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.46 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996831 | CMS |
| ABBVIE INC. | $21.88 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996833 | CMS |
| ABBVIE INC. | $26.08 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996835 | CMS |
| ABBVIE INC. | $32.15 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996837 | CMS |
| ABBVIE INC. | $3.21 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996839 | CMS |
| ABBVIE INC. | $23.50 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996841 | CMS |
| Grifols USA, LLC | $133.52 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124719694 | CMS |
| SK Life Science, Inc. | $29.17 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150784 | CMS |
| Teva Pharmaceuticals USA, Inc. | $117.66 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151612920 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.